Reviva Pharmaceuticals Holdings Inc. Ordinary Shares RVPH 深 滬
等待開盤 09-20 09:30:00 美东时间
1.31
-0.070
-5.07%
華盛通- 最 高1.50
- 今 開1.42
- 成交量 43.74万股
- 最 低 1.25
- 昨 收 1.38
- 總市值 3657.34万
- 52周最高 6.80
- 市盈率 靜 --
- 換手率 1.57%
- 52周最低 0.60
- 委 比 -40.00%
- 總股本 2791.86万
- 歷史最高 15.10
- 量 比 1.08
- 振 幅 18.12%
- 歷史最低 0.00
- 每 手 1
- 風險率 1.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | Reviva Pharmaceuticals控股有限公司 - 统计学上显著的声音生物标志数据加强了Brilaroxazine的功效
Reviva Pharmaceuticals Holdings, Inc. - Statistically Significant Vocal Biomark...
09-09 20:03
Reviva Pharmaceuticals Launches Multi-Million Share Offering
The latest update is out from Reviva Pharmaceuticals Holdings (RVPH). Reviva Ph...
08-22 05:49
Reviva Announces Grant Of U.S. Patent 12053477 Covering Use Of Brilaroxazine For The Treatment Of Idiopathic Pulmonary Fibrosis
CUPERTINO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- -Similar patent has also been granted in Japan -Brilaroxazine has received Orphan Drug Designation for the treatment of idiopathic pulmonary fibrosis
08-06 20:04
Reviva Pharmaceuticals Secures European Patent for Brilaroxazine
An announcement from Reviva Pharmaceuticals Holdings (RVPH) is now available. R...
07-09 21:28
Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key Companies - Novo Nordisk A/S, Pfizer, Boehringer Ingelheim, Eli Lilly and Company, Rhythm Pharmaceuticals, Harmony Biosciences
The obesity market size is projected to witness growth from 2024 to 2034 due to...
06-19 05:31
Reviva Pharmaceuticals looks to raise $3M through direct offering; shares fall
Reviva Pharmaceuticals (NASDAQ:RVPH) said it is looking to raise $3M through the sale and issuance of 1.89M shares, warrants to buy up to 1.89M shares at a combined offering price of $1.58 apiece. Sha...
05-28 20:45
Maxim Group Remains a Buy on Reviva Pharmaceuticals Holdings (RVPH)
In a report released yesterday, Jason McCarthy from Maxim Group maintained a Bu...
05-17 03:35
Reviva Pharmaceuticals Progresses with Global Schizophrenia Trial
Reviva Pharmaceuticals Holdings (RVPH) just unveiled an announcement. Reviva Ph...
05-15 20:22
Reviva Pharmaceuticals GAAP EPS of -$0.25
Reviva Pharmaceuticals press release (NASDAQ:RVPH): Q1 GAAP EPS of -$0.25. As of March 31, 2024, the Company’s cash totaled approximately $12.0 million compared to approximately $23.4 million as of De...
05-14 22:50
Reviva Pharmaceuticals Q1 EPS $(0.25) Beats $(0.42) Estimate
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.25) per s...
05-14 20:29
